Arbutus Biopharma (ABUS) Amortization - Goodwill (2019)
Arbutus Biopharma recorded quarterly Amortization - Goodwill of $22.5 million in Q3 2019.
Arbutus Biopharma's Amortization - Goodwill history runs 1 years deep, the most recent figure standing at $22.5 million for Q3 2019.
- In Q3 2019, Amortization - Goodwill changed N/A year-over-year to $22.5 million; the TTM figure through Dec 2020 stood at $22.5 million (changed 0.0% YoY), while the FY2019 annual figure was $22.5 million, changed N/A from the prior year.
- Amortization - Goodwill came in at $22.5 million for Q3 2019 at Arbutus Biopharma.
- In the past five years, Amortization - Goodwill ranged from a high of $22.5 million in Q3 2019 to a low of $22.5 million in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Arbutus Biopharma | 883.58 Mn | 883.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 22.47 Mn |